Mesirow Financial Investment Management, Inc. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mesirow Financial Investment Management, Inc. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$224,228
-39.6%
3,862
-44.0%
0.98%
-37.9%
Q2 2023$370,996
+35.5%
6,8920.0%1.57%
+38.5%
Q1 2023$273,750
-1.3%
6,8920.0%1.14%
-2.5%
Q4 2022$277,265
+24.9%
6,8920.0%1.16%
+10.3%
Q3 2022$222,000
+8.8%
6,8920.0%1.06%
+6.9%
Q2 2022$204,000
-64.0%
6,892
-43.9%
0.99%
-39.6%
Q4 2021$566,000
+40.4%
12,2770.0%1.63%
+37.7%
Q3 2021$403,000
+27.9%
12,277
+36.8%
1.19%
+47.3%
Q2 2021$315,000
-2.5%
8,974
+0.3%
0.80%
-8.3%
Q1 2021$323,000
-99.9%
8,950
-4.1%
0.88%
+2.5%
Q4 2020$270,943,000
+101758.3%
9,330
-1.1%
0.86%
-24.8%
Q3 2020$266,000
+0.4%
9,433
+15.3%
1.14%
-8.7%
Q2 2020$265,000
-0.7%
8,181
+25.1%
1.25%
-25.8%
Q1 2020$267,000
-24.4%
6,542
+14.3%
1.68%
+12.9%
Q4 2019$353,000
-36.6%
5,723
-25.2%
1.49%
-36.4%
Q3 2019$557,000
-17.2%
7,649
-6.0%
2.34%
-4.6%
Q2 2019$673,000
-7.6%
8,139
-21.1%
2.46%
-15.1%
Q1 2019$728,000
+130.4%
10,315
+46.8%
2.89%
+41.8%
Q4 2018$316,000
-20.4%
7,0270.0%2.04%
-0.3%
Q3 2018$397,000
-35.8%
7,027
-24.1%
2.05%
-25.5%
Q2 2018$618,000
+69.3%
9,255
+47.7%
2.74%
+78.6%
Q1 2018$365,000
+62.2%
6,264
+79.2%
1.54%
+50.7%
Q4 2017$225,000
-61.3%
3,496
-68.5%
1.02%
-62.8%
Q3 2017$582,000
+15.0%
11,096
+2.6%
2.74%
+14.7%
Q2 2017$506,00010,8162.39%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders